NanoViricides Files Quarterly Report for Period Ending March 31, 2019 – HerpeCide™ Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials – Yahoo Finance

NanoViricides Files Quarterly Report for Period Ending March 31, 2019 – HerpeCide™ Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials Yahoo Finance

SHELTON, Conn., May 20, 2019 /PRNewswire/ — NanoViricides, Inc. (NYSE MKT: NNVC) (the “Company”) a global leader in the development of highly effective …